Form 4: Dyne Therapeutics Executive Sells Shares to Cover Tax Obligations
SEC Form 4
Richard William Scalzo, SVP, Head of Finance & Admin. at Dyne Therapeutics, sold shares to cover tax obligations related to vesting restricted stock units.
Summary
- Richard William Scalzo, SVP, Head of Finance & Admin. at Dyne Therapeutics, sold shares of common stock on August 19, 2024.
- The sales were executed in two transactions at weighted average prices of $45.01 and $46.
- A total of 2,752 shares were sold to cover tax withholding obligations related to the vesting of restricted stock units.
- Following the transactions, Scalzo directly owns 111,022 shares of Dyne Therapeutics, which includes 101,426 unvested RSUs.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine transaction to cover tax obligations, not necessarily indicative of the executive's view on the company's future prospects.
Industry Context
This is a routine Form 4 filing related to insider selling to cover tax obligations, which is a common practice among executives who receive equity compensation. It doesn't necessarily indicate a negative outlook on the company.
Key Dates
| Date | Description |
|---|---|
| 01/25/2024 | Date of entry into a Rule 10b5-1 trading plan. |
| 11/15/2023 | Date of grant of restricted stock units to the Reporting Person. |
| 08/19/2024 | Date of the share sale transactions. |
| 08/20/2024 | Date of signature of the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.